Development of mGluR5 Antagonists to Treat Fragile X Syndrome and Autism

Information

• Research Project
• 7694103

• ApplicationId

  7694103

• Core Project Number

  U01MH078270

• Full Project Number

  3U01MH078270-02S1

• Serial Number

  78270

• FOA Number

  PA-05-08

• Sub Project Id

• Project Start Date

  4/1/2007 - 17 years ago

• Project End Date

  3/31/2010 - 14 years ago

• Program Officer Name

  RIDDLE, ROBERT D

• Budget Start Date

  9/30/2008 - 16 years ago

• Budget End Date

  3/31/2009 - 15 years ago

• Fiscal Year

  2008

• Support Year

  2

• Suffix

  S1

• Award Notice Date

  9/26/2008 - 16 years ago

Organizations

• Seaside Therapeutics, Inc.

IC Name

• Activity

  U01

• Administering IC

  MH

• Application Type

  3

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  2587460

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

  865

• Ed Inst. Type

• Funding ICs

  NICHD:2587460\

• Funding Mechanism

• Study Section

  ZMH1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  SEASIDE THERAPEUTICS, LLC

• Organization Department

• Organization DUNS

  605835888

• Organization City

  CAMBRIDGE

• Organization State

  MA

• Organization Country

  UNITED STATES

• Organization Zip Code

  02139

• Organization District

  UNITED STATES